Curium Join Forces With PeptiDream For Prostate Cancer Theranostics in Japan
KUALA LUMPUR, Curium, a world leader in nuclear medicine, has entered into a strategic partnership with PDRadiopharma Inc, a wholly-owned subsidiary of PeptiDream, for the clinical development, regulatory filing, and commercialisation in Japan of two…